ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 201 filers reported holding ASCENDIS PHARMA A/S in Q2 2024. The put-call ratio across all filers is 1.83 and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Q Global Advisors, LLC | 219,459 | $29,930 | 21.23% |
| RA Capital Management | 10,108,400 | $1,378,583,592 | 18.23% |
| Tri Locum Partners LP | 227,762 | $31,062,182 | 7.85% |
| Vestal Point Capital, LP | 750,000 | $102,285,000 | 7.63% |
| Avoro Capital Advisors LLC | 4,196,661 | $572,340,627 | 7.62% |
| Finepoint Capital LP | 189,272 | $25,812,915 | 7.33% |
| Spyglass Capital Management LLC | 662,888 | $90,404,665 | 6.62% |
| Saturn V Capital Management LP | 113,224 | $15,441,489 | 5.84% |
| Sofinnova Investments, Inc. | 734,284 | $100,141,652 | 5.20% |
| First Turn Management, LLC | 186,581 | $25,445,917 | 4.14% |